Logo

Tm Bioscience to Raise CA$7.5 Million in Private Placement

Jan 19, 2005

NEW YORK, Jan. 19 (GenomeWeb News) - Tm Bioscience expects to raise CA$7.5 million ($6.13 million) through a private placement of 3.5 million common shares with a syndicate of underwriters, the company said today.

 

The Toronto-based genetic test developer said that it would sell the shares at a price of $2.15 each. Tm's shares traded down 6.75 percent at $2.21 in morning trade on the Toronto Stock Exchange.

 

The syndicate of underwriters is led by Orion Securities and includes Dlouhy Merchant Group. Tm expects to close the private placement on Feb. 3.

Breaking News
The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.